ESC 365 - Highlights from HELIOS-B - Primary results from phase 3 study of vutrisiran in patients with transthyretin amyloidosis with cardiomyopathy

ESC Professional Premium Access

Highlights from HELIOS-B - Primary results from phase 3 study of vutrisiran in patients with transthyretin amyloidosis with cardiomyopathy

Session: Daily Highlights by the Taiwan Society of Cardiology

Topic: European Society of Cardiology

Speaker: Doctor Y. Wu (New Taipei, TW)

Event: ESC Congress 2024

Congress Presentation

Add to my library

About the speaker

Doctor Yen-Wen Wu

Far Eastern Memorial Hospital, New Taipei (Taiwan)

1 presentation

0 follower

3 more presentations in this session

Highlights on 2024 ESC Guidelines for the Management of Elevated Blood Pressure and Hypertension and from BedMed/BedMed-Frail

Speaker: Professor T. Wang (Taipei, TW)

Highlights from FINEARTS-HF and FINE-HEART: the role of finerenone in heart failure

Speaker: Professor P. Liu (Tainan, TW)

Daily Highlights by the Taiwan Society of Cardiology - panel discussion

Access the full session

Daily Highlights by the Taiwan Society of Cardiology

Speakers: Doctor Y. Wu, Professor T. Wang, Professor P. Liu

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources